Elypta (private company)
See something wrong or missing? Let us know
Offices:Gothenburg, Stockholm
Industry:BiotechHealth services
Business model:B2B
Elypta is a molecular diagnostic company focused on preventing cancer mortality by developing a liquid biopsy platform for detection and monitoring of the disease. The approach is based on measurement of 20 biomarkers and use of machine learning algorithms to generate a score against cancer-type specific signatures.
Investors:
we tracked 8 investors
You need an account to access this feature. Log in or create one from here.
Do you have a question? Talk to us.
values in USD
Investments 27.65M
You need an account to access this feature. Log in or create one from here.
Do you have a question? Talk to us.
Companies with similar profile to Elypta
Name | Criteria | |
---|---|---|
![]() |
Atai Life Sciences
57%
|
|
![]() |
Biofidelity
57%
|
|
![]() |
BoneSupport
57%
|
|
![]() |
CatalYm
57%
|
|
![]() |
Galecto Biotech
57%
|
|
![]() |
LabGenius
57%
|
|
![]() |
MedTrace
57%
|
|
![]() |
MinervaX
57%
|
|
![]() |
Muna Therapeutics
57%
|
|
![]() |
NMD Pharma
57%
|
|